ArticleFrontiers in oncology2021

Development and Validation of a Novel Model for Predicting Prognosis of Non-PCR Patients After Neoadjuvant Therapy for Breast Cancer.

Yongqiang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.